Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Risk of Hepatic Decompensation and Hepatocellular Carcinoma in Advanced Fibrotic or Cirrhotic Patients With Chronic Hepatitis C After Sustained Virologic Response

NCT07687758 is registered in ClinicalTrials.gov with Siriraj Hospital as lead sponsor.

NCT NCT07687758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07687758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Risk of Hepatic Decompensation and Hepatocellular Carcinoma in Advanced Fibrotic or Cirrhotic Patients With Chronic Hepatitis C After Sustained Virologic Response
Lead sponsor
Siriraj Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2013
Completion date
July 31, 2023
Enrollment
571 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

compensated advanced chronic liver disease, hepatitis c virus infection, hepatocellular carcinoma (hcc)